Left main coronary artery stenosis: state-of-the-art
Ayman A El-Menyar1, Jassim Al Suwaidi, David R Holmes
1Weill Cornell Medical School, Qatar.
Insights
Left main coronary artery stenosis poses significant risks, with surgical revascularization historically favored. Advances in stenting and intravascular ultrasound offer new options, but outcomes depend on lesion location, thrombosis risk, and patient factors. Ongoing trials compare stenting to bypass surgery.
Area of Science:
- Cardiology
- Interventional Cardiology
- Vascular Surgery
Background:
- Left main coronary artery stenosis presents significant mortality risks.
- Surgical revascularization is the traditional treatment of choice.
- Advances in interventional cardiology are changing treatment paradigms.
Purpose of the Study:
- To review current challenges and evolving treatment strategies for left main coronary artery stenosis.
- To highlight the impact of new technologies like intravascular ultrasound and drug-eluting stents.
- To discuss ongoing clinical trials evaluating percutaneous coronary intervention versus coronary artery bypass graft surgery.
Main Methods:
- Review of current literature and clinical guidelines.
- Discussion of findings from major clinical trials (SYNTAX, COMBAT).
- Analysis of factors influencing treatment decisions, including lesion characteristics and patient comorbidities.
Main Results:
- Distal bifurcation left main disease is associated with worse outcomes.
- Subacute thrombosis remains a concern with stenting.
- Left ventricular function and comorbidities significantly impact patient prognosis.
- Risk-benefit ratios of stenting versus bypass surgery are under active investigation.
Conclusions:
- Optimal management of left main coronary artery stenosis requires careful consideration of lesion location, patient factors, and emerging evidence.
- Ongoing trials are crucial for defining the role of drug-eluting stents versus coronary artery bypass graft surgery.
- The field continues to evolve, necessitating continuous evaluation of treatment modalities and patient selection criteria.
Abstract:
Patients with stenosis of the left main coronary artery present difficult challenges. The risks associated with this lesion have been known since the early days of angiography when patients were found to have increased mortality during follow-up. This information led to the general guidelines that surgical revascularization should be considered the treatment of choice in patients with significant left main coronary artery stenosis. Current advances in invasive cardiology have brought important information to the field. Intravascular ultrasound is now used routinely to evaluate angiographically indeterminate lesions with criteria now set forward as to what constitutes an indication for revascularization. Stents have even further dramatically changed the landscape. There are substantial issues, however, that need to addressed. These include the following: (1) the effect of specific lesion location on outcome - it is known that patients with distal bifurcation left main disease have worse outcome; (2) the potential for subacute thrombosis of the left main coronary artery; (3) the impact of left ventricular function and patient comorbidities irrespective of the degree and location of left main coronary artery stenosis; and (4) the risk-benefit ratio of stenting versus coronary artery bypass graft surgery. These issues are currently being addressed in two seminally important trials including the SYNTAX trial, which randomizes patients with left main and/or three-vessel disease to either coronary artery bypass graft surgery or a TAXUS drug-eluting stent. This trial is in the final stages of patient recruitment and will have important implications for the field. The other trial is the COMBAT trial, which is focused exclusively on left main coronary artery stenosis and randomizes patients with left main coronary artery disease either to a Sirolimus-eluting stent (Cypher, Johnson and Johnson Cordis, USA) or to coronary artery bypass graft surgery. The field of left main coronary artery disease continues to expand in terms of the evidence available for optimal patient evaluation and selection of treatment modalities.
Related Concept Videos
01:30Acute Coronary Syndrome I: Introduction
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:23Mitral Stenosis II: Clinical features and Diagnostic Tests
01:27Coronary Artery Disease V: Interprofessional Care
01:24Cardiac Catheterization III: Left Heart Catheterization
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...